Biotechnology Leader LuminUltra Submits COVID-19 Clinical Diagnostic Testing Kit for Regulatory Authorization in U.S., Canada
- Monday, September 14, 2020, 7:18
- Business
- Add a comment
End-to-end solution and components offer flexibility to testing facilities, meeting high-volume demand and significantly boosting global testing capacity FREDERICTON, NB, Sept. 14, 2020 /PRNewswire/ – Canada-based biotechnology front-runner LuminUltra announced today that it has submitted…